New Weight-Loss drug zovaglutide heads to phase 3 trial

NCT ID NCT07230119

First seen Nov 17, 2025 · Last updated May 15, 2026 · Updated 23 times

Summary

This study tests a new drug, zovaglutide, to help adults with overweight or obesity lose weight. About 744 people will receive either the drug or a placebo for 52 weeks. The main goal is to see how much weight they lose and if at least 5% of body weight is lost.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVERWEIGHT , OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Central Hospital Affiliated to Shandong First Medical University

    Jinan, Shandong, 250000, China

  • First Hospital of Qinhuangdao

    Qinhuangdao, Hebei, 066000, China

  • Gansu Provincial Hospital

    Lanzhou, Gansu, 730099, China

    Contact

  • Guangzhou Red Cross Hospital

    Guangzhou, Guangdong, 510235, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Handan First Hospital

    Handan, Hebei, 056002, China

  • Hebei Petro China Cental Hospital

    Langfang, Hebei, 065000, China

  • Huizhou Central People's Hospital

    Huizhou, Guangdong, 516008, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Luoyang Third People's Hospital

    Luoyang, Henan, 471002, China

  • Nanjing Jiangning Hospital

    Nanjing, Jiangsu, 210000, China

  • Nanyang Second People's Hospital

    Nanyang, Henan, 473009, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Peking University People's Hospital

    Beijing, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Affiliated Hospital of Xuzhou Medical University

    Xuzhou, Jiangsu, 221006, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The First Affiliated Hospital of Henan University of Science & Technology

    Luoyang, Henan, 471000, China

  • The First Affiliated of Nanyang Medical College

    Nanyang, Henan, 473000, China

  • The Fourth Affiliated Hospital Harbin Medical University

    Harbin, Heilongjiang, 150001, China

  • The Second Affiliated Hospital of Nanjing Medical University

    Nanjing, Jiangsu, 210011, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Second Affiliated Hospotal of Guangxi Medical University

    Nanning, Guangxi, 530006, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Second Hospital of Hebei Medical University

    Shijiangzhuang, Hebei, 050005, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Second People's Hospital of Lianyungang

    Lianyungang, Jiangsu, 222002, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Xi'an Daxing Hospital

    Xi’an, Shanxi, 710000, China

  • Xuancheng People's Hospital

    Xuancheng, Anhui, 242099, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Yichang Central People's Hospital

    Yichang, Hubei, 443003, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Yueyang People's Hospital

    Yueyang, Hunan, 414022, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Zhuzhou Central Hospital

    Zhuzhou, Hunan, 412007, China

    Contact

  • Zibo Municipal Hospital

    Zibo, Shandong, 255400, China

Conditions

Explore the condition pages connected to this study.